Clinical Trial Update: TLI & ATG for Non-Myeloablative Allogeneic Transplantation for MDS and MPD [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating non-myeloablative allogeneic transplantation using total lymphoid irradiation (TLI) with anti-thymocyte globulin (ATG) for myelodysplas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes
• Myeloproliferative Neoplasms

Drugs mentioned

• Anti-thymocyte globulin (ATG) (anti-thymocyte globulin)
• Total lymphoid irradiation

Snippet

Sponsor: Stanford University | Conditions: Myeloproliferative Disorders, Blood Cancer | Phase 2 | Status: COMPLETED